- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 354582, 13 pages
Comparative Gene Expression Profiling in Human Cumulus Cells according to Ovarian Gonadotropin Treatments
1Université Montpellier 1, UFR de Médecine, Montpellier, France
2CHU Montpellier, Institute for Research in Biotherapy, Hôpital Saint-Eloi, INSERM U1040, 34295 Montpellier, France
3ART-PGD Department, CHU Montpellier, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France
Received 7 June 2013; Accepted 8 August 2013
Academic Editor: Shivani Soni
Copyright © 2013 Said Assou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- G. H. Trew, A. P. Brown, S. Gillard et al., “In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review,” Reproductive Biology and Endocrinology, vol. 8, article 137, 2010.
- M. van Wely, I. Kwan, A. L. Burt et al., “Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A cochrane review,” Human Reproduction Update, vol. 18, no. 2, p. 111, 2012.
- M. van Wely, I. Kwan, A. L. Burt et al., “Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD005354, 2011.
- K. J. Hutt and D. F. Albertini, “An oocentric view of folliculogenesis and embryogenesis,” Reproductive BioMedicine Online, vol. 14, no. 6, pp. 758–764, 2007.
- D. F. Albertini, C. M. H. Combelles, E. Benecchi, and M. J. Carabatsos, “Cellular basis for paracrine regulation of ovarian follicle development,” Reproduction, vol. 121, no. 5, pp. 647–653, 2001.
- S. Assou, D. Haouzi, K. Mahmoud et al., “A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study,” Molecular Human Reproduction, vol. 14, no. 12, pp. 711–719, 2008.
- L. J. McKenzie, S. A. Pangas, S. A. Carson et al., “Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF,” Human Reproduction, vol. 19, no. 12, pp. 2869–2874, 2004.
- A. P. A. van Montfoort, J. P. M. Geraedts, J. C. M. Dumoulin, A. P. M. Stassen, J. L. H. Evers, and T. A. Y. Ayoubi, “Differential gene expression in cumulus cells as a prognostic indicator of embryo viability: a microarray analysis,” Molecular Human Reproduction, vol. 14, no. 3, pp. 157–168, 2008.
- K. M. Gebhardt, D. K. Feil, K. R. Dunning, M. Lane, and D. L. Russell, “Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer,” Fertility and Sterility, vol. 96, no. 1, pp. 47.e2–52.e2, 2011.
- M. Hamel, I. Dufort, C. Robert et al., “Identification of differentially expressed markers in human follicular cells associated with competent oocytes,” Human Reproduction, vol. 23, no. 5, pp. 1118–1127, 2008.
- S. Assou, I. Boumela, D. Haouzi et al., “Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications,” Human Reproduction Update, vol. 17, no. 2, pp. 272–290, 2011.
- R. A. Anderson, R. Sciorio, H. Kinnell et al., “Cumulus gene expression as a predictor of human oocyte fertilisation, embryo development and competence to establish a pregnancy,” Reproduction, vol. 138, no. 4, pp. 629–637, 2009.
- T. Adriaenssens, S. Wathlet, I. Segers et al., “Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics,” Human Reproduction, vol. 25, no. 5, pp. 1259–1270, 2010.
- Z. G. Ouandaogo, D. Haouzi, S. Assou et al., “Human cumulus cells molecular signature in relation to oocyte nuclear maturity stage,” PLoS One, vol. 6, no. 11, Article ID e27179, 2011.
- S. Assou, T. Anahory, V. Pantesco et al., “The human cumulus-oocyte complex gene-expression profile,” Human Reproduction, vol. 21, no. 7, pp. 1705–1719, 2006.
- E. Fragouli, D. Wells, A. E. Iager, U. A. Kayisli, and P. Patrizio, “Alteration of gene expression in human cumulus cells as a potential indicator of oocyte aneuploidy,” Human Reproduction, vol. 27, pp. 2559–2568, 2012.
- S. Assou, D. Haouzi, J. de Vos, and S. Hamamah, “Human cumulus cells as biomarkers for embryo and pregnancy outcomes,” Molecular Human Reproduction, vol. 16, no. 8, pp. 531–538, 2010.
- J. Balasch, J. Peñarrubia, F. Fábregues et al., “Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction,” Reproductive BioMedicine Online, vol. 7, no. 1, pp. 35–42, 2003.
- Z. Kilani, A. Dakkak, S. Ghunaim et al., “A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes,” Human Reproduction, vol. 18, no. 6, pp. 1194–1199, 2003.
- P. Platteau, A. N. Andersen, A. Balen et al., “Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study,” Human Reproduction, vol. 21, no. 7, pp. 1798–1804, 2006.
- S. Daya, “Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction,” Fertility and Sterility, vol. 77, no. 4, pp. 711–714, 2002.
- A. Coomarasamy, M. Afnan, D. Cheema, F. van der Veen, P. M. M. Bossuyt, and M. van Wely, “Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis,” Human Reproduction, vol. 23, no. 2, pp. 310–315, 2008.
- S. Ziebe, K. Lundin, R. Janssens, L. Helmgaard, and J.-C. Arce, “Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF,” Human Reproduction, vol. 22, no. 9, pp. 2404–2413, 2007.
- M. L. Grøndahl, R. Borup, Y. B. Lee, V. Myrhøj, H. Meinertz, and S. Sørensen, “Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin,” Fertility and Sterility, vol. 91, no. 5, pp. 1820–1830, 2009.
- J. Brannian, K. Eyster, B. A. Mueller, M. G. Bietz, and K. Hansen, “Differential gene expression in human granulosa cells from recombinant FSH versus human menopausal gonadotropin ovarian stimulation protocols,” Reproductive Biology and Endocrinology, vol. 8, article 25, 2010.
- P. Devroey, A. Pellicer, A. Nyboe Andersen, and J.-C. Arce, “A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer,” Fertility and Sterility, vol. 97, no. 3, pp. 561–571, 2012.
- D. K. Gardner and W. B. Schoolcraft, “Culture and transfer of human blastocysts,” Current Opinion in Obstetrics and Gynecology, vol. 11, no. 3, pp. 307–311, 1999.
- D. K. Gardner, W. B. Schoolcraft, L. Wagley, T. Schlenker, J. Stevens, and J. Hesla, “A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization,” Human Reproduction, vol. 13, no. 12, pp. 3434–3440, 1998.
- M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998.
- S. Assou, I. Boumela, D. Haouzi, et al., “Transcriptome analysis during human trophectoderm specification suggests new roles of metabolic and epigenetic genes,” PLoS One, vol. 7, no. 6, Article ID e39306, 2012.
- B. L. Dozier, K. Watanabe, and D. M. Duffy, “Two pathways for prostaglandin F2α synthesis by the primate periovulatory follicle,” Reproduction, vol. 136, no. 1, pp. 53–63, 2008.
- A. Regassa, F. Rings, M. Hoelker et al., “Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells,” BMC Genomics, vol. 12, article no. 57, 2011.
- D. Szöllösi, “On the role of gap junctions between follicle cells and oocyte in the mammalian ovarian follicle,” Research Communications in Chemical Pathology and Pharmacology, vol. 10, no. 2, pp. 3–4, 1978.
- K. R. Dunning, K. Cashman, D. L. Russell, J. G. Thompson, R. J. Norman, and R. L. Robker, “Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development,” Biology of Reproduction, vol. 83, no. 6, pp. 909–918, 2010.
- T. G. McEvoy, G. D. Coull, P. J. Broadbent, J. S. M. Hutchinson, and B. K. Speake, “Fatty acid composition of lipids in immature cattle, pig and sheep oocytes with intact zona pellucida,” Journal of Reproduction and Fertility, vol. 118, no. 1, pp. 163–170, 2000.
- D. L. Russell and R. L. Robker, “Molecular mechanisms of ovulation: co-ordination through the cumulus complex,” Human Reproduction Update, vol. 13, no. 3, pp. 289–312, 2007.
- C. Fülöp, S. Szántó, D. Mukhopadhyay et al., “Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice,” Development, vol. 130, no. 10, pp. 2253–2261, 2003.
- H. J. Song, E. J. Kang, G. H. Maeng et al., “Influence of epidermal growth factor supplementation during in vitro maturation on nuclear status and gene expression of canine oocytes,” Research in Veterinary Science, vol. 91, no. 3, pp. 439–445, 2011.
- M. Assidi, S. J. Dieleman, and M.-A. Sirard, “Cumulus cell gene expression following the LH surge in bovine preovulatory follicles: potential early markers of oocyte competence,” Reproduction, vol. 140, no. 6, pp. 835–852, 2010.
- Y. Shimada, Y.-T. Li, and S.-C. Li, “Effect of GM2 activator protein on the enzymatic hydrolysis of phospholipids and sphingomyelin,” Journal of Lipid Research, vol. 44, no. 2, pp. 342–348, 2003.
- G. F. Erickson, V. G. Garzo, and D. A. Magoffin, “Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells,” Journal of Clinical Endocrinology and Metabolism, vol. 69, no. 4, pp. 716–724, 1989.
- C. I. Friedman, D. B. Seifer, E. A. Kennard, L. Arbogast, B. Alak, and D. R. Danforth, “Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential,” Fertility and Sterility, vol. 70, no. 5, pp. 836–839, 1998.
- J.-Y. Park, Y.-Q. Su, M. Ariga, E. Law, S.-L. C. Jin, and M. Conti, “EGF-like growth factors as mediators of LH action in the ovulatory follicle,” Science, vol. 303, no. 5658, pp. 682–684, 2004.
- H. Ashkenazi, X. Cao, S. Motola, M. Popliker, M. Conti, and A. Tsafriri, “Epidermal growth factor family members: endogenous mediators of the ovulatory response,” Endocrinology, vol. 146, no. 1, pp. 77–84, 2005.
- Z. G. Ouandaogo, N. Frydman, L. Hesters, et al., “Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo and in vitro oocyte maturation,” Human Reproduction, vol. 27, pp. 2438–2447, 2012.
- R.-C. Chian, A. Ao, H. J. Clarke, T. Tulandi, and S.-L. Tan, “Production of steroids from human cumulus cells treated with different concentrations of gonadotropins during culture in vitro,” Fertility and Sterility, vol. 71, no. 1, pp. 61–66, 1999.
- P. Kempná, M. Körner, B. Waser et al., “Neuropeptide Y modulates steroid production of human adrenal H295R cells through Y1 receptors,” Molecular and Cellular Endocrinology, vol. 314, no. 1, pp. 101–109, 2010.
- A. Barreca, B. Valli, A. Cesarone et al., “Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture,” Fertility and Sterility, vol. 70, no. 2, pp. 320–325, 1998.
- M. Körner, B. Waser, and J. C. Reubi, “Neuropeptide Y receptor expression in human primary ovarian neoplasms,” Laboratory Investigation, vol. 84, no. 1, pp. 71–80, 2004.
- Y.-J. Yi, E. Nagyova, G. Manandhar et al., “Proteolytic activity of the 26S proteasome is required for the meiotic resumption, germinal vesicle breakdown, and cumulus expansion of porcine cumulus-oocyte complexes matured in vitro,” Biology of Reproduction, vol. 78, no. 1, pp. 115–126, 2008.
- F. Cillo, T. A. L. Brevini, S. Antonini, A. Paffoni, G. Ragni, and F. Gandolfi, “Association between human oocyte developmental competence and expression levels of some cumulus genes,” Reproduction, vol. 134, no. 5, pp. 645–650, 2007.
- S. A. Pangas, C. J. Jorgez, and M. M. Matzuk, “Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32281–32286, 2004.
- T. G. Golos and J. F. Strauss III, “8-Bromoadenosine cyclic 3′5′-phosphate rapidly increases 3-hydoxy-3-methylglutaryl coenzyme a reductase mRNA in human granulosa cells: role of cellular sterol balance in controlling the response to tropic stimulation,” Biochemistry, vol. 27, no. 9, pp. 3503–3506, 1988.
- H. Watanabe, S. Hirai, H. Tateno, and Y. Fukui, “Variation of cholesterol contents in porcine cumulus-oocyte complexes is a key factor in regulation of fertilizing capacity,” Theriogenology, vol. 79, pp. 680–686, 2013.
- X. Zhang, N. Jafari, R. B. Barnes, E. Confino, M. Milad, and R. R. Kazer, “Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality,” Fertility and Sterility, vol. 83, no. 4, supplement 1, pp. 1169–1179, 2005.
- A. Chakraborty, H. Brooks, P. Zhang et al., “Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes,” American Journal of Physiology—Renal Physiology, vol. 292, no. 2, pp. F895–F904, 2007.
- M. Paciga, C. R. McCudden, C. Londos, G. E. DiMattia, and G. F. Wagner, “Targeting of big stanniocalcin and its receptor to lipid storage droplets of ovarian steroidogenic cells,” The Journal of Biological Chemistry, vol. 278, no. 49, pp. 49549–49554, 2003.
- G. Basini, S. Bussolati, S. E. Santini et al., “Antiangiogenesis in swine ovarian follicle: a potential role for 2-methoxyestradiol,” Steroids, vol. 72, no. 8, pp. 660–665, 2007.
- G. Basini, L. Baioni, S. Bussolati et al., “Expression and localization of stanniocalcin 1 in swine ovary,” General and Comparative Endocrinology, vol. 166, no. 2, pp. 404–408, 2010.
- G. Basini, S. Bussolati, S. E. Santini et al., “Hydroxyestrogens inhibit angiogenesis in swine ovarian follicles,” Journal of Endocrinology, vol. 199, no. 1, pp. 127–135, 2008.
- J. Lim and U. Luderer, “Oxidative damage increases and antioxidant gene expression decreases with aging in the mouse ovary,” Biology of Reproduction, vol. 84, no. 4, pp. 775–782, 2011.
- Y. Ziv, D. Bielopolski, Y. Galanty et al., “Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM-and KAP-1 dependent pathway,” Nature Cell Biology, vol. 8, no. 8, pp. 870–876, 2006.